Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Gastrointestinal Stromal Tumours (GIST): Indian Experience of Rare Malignancy

Gastrointestinal Stromal Tumours (GIST): Indian Experience of Rare Malignancy GISTs are rare tumours of the GI tract arising from the intestinal cells of Cajal. Though various risk stratification systems have been proposed, none has been universally accepted. We audited the survival and recurrence patterns in our patients and evaluated clinicopathological features to identify prognostic factors affecting survival. We conducted a retrospective analysis of patients treated at our hospital from 1999 to 2012. Patient variables, clinicopathological factors and treatment variables were collected. Sixty-three patients were evaluated and treated at our institute of which 38 were non-metastatic. The most common site of origin was the stomach. On univariate analysis, presence of metastasis, male gender, high mitotic rate, non-gastric primary and epithelioid histology were significantly associated with poor overall survival. Tumour size > 10 cm, mitotic rate > 10/50 hpf and presence of necrosis significantly affected disease-free survival for non-metastatic patients. Multivariate analysis showed higher mitotic rate and non-gastric primary to correlate with worse outcome. In our experience, a high mitotic rate and non-gastric primary independently predicted a poor prognosis in GIST. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png "Indian Journal of Surgical Oncology" Springer Journals

Gastrointestinal Stromal Tumours (GIST): Indian Experience of Rare Malignancy

Loading next page...
 
/lp/springer-journals/gastrointestinal-stromal-tumours-gist-indian-experience-of-rare-6rH2h04uN0

References (40)

Publisher
Springer Journals
Copyright
Copyright © Indian Association of Surgical Oncology 2020
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-020-01095-6
Publisher site
See Article on Publisher Site

Abstract

GISTs are rare tumours of the GI tract arising from the intestinal cells of Cajal. Though various risk stratification systems have been proposed, none has been universally accepted. We audited the survival and recurrence patterns in our patients and evaluated clinicopathological features to identify prognostic factors affecting survival. We conducted a retrospective analysis of patients treated at our hospital from 1999 to 2012. Patient variables, clinicopathological factors and treatment variables were collected. Sixty-three patients were evaluated and treated at our institute of which 38 were non-metastatic. The most common site of origin was the stomach. On univariate analysis, presence of metastasis, male gender, high mitotic rate, non-gastric primary and epithelioid histology were significantly associated with poor overall survival. Tumour size > 10 cm, mitotic rate > 10/50 hpf and presence of necrosis significantly affected disease-free survival for non-metastatic patients. Multivariate analysis showed higher mitotic rate and non-gastric primary to correlate with worse outcome. In our experience, a high mitotic rate and non-gastric primary independently predicted a poor prognosis in GIST.

Journal

"Indian Journal of Surgical Oncology"Springer Journals

Published: Sep 22, 2020

There are no references for this article.